Clinical Trial Update: Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating dasatinib in combination with gemcitabine for locally advanced pancreatic cancer has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• DASATINIB (Dasatinib)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED | Results posted: 2015-03-17